Summary: Factors are examined in this report which govern the uniqueness and sensitivity of regional cerebral blood flow (rCBF), as determined by an in vivo autora diographic strategy and positron emission tomography (PET), and a series of theorems is derived which specify conditions under which a unique relationship between cu mulative cranial activity of the tracer (C) and regional blood flow (f) may be assured. It is demonstrated that, independent of the specific form of the arterial tracer input function, flow is a unique function of C whenever the start time (TI) of the PET scan is coincident with the start of tracer infusion. Other theorems state that, even for nonzero TIs, a unique solution for flow may be ex pected, as long as the duration of the scan is sufficiently short. The implementation of this theory is illustrated using arterial tracer activity curves obtained in three normal subjects by a mUltiple arterial sampling procedure
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In a recent publication in this journal, Ginsberg et al. (1982) proposed an in vivo autoradiographic strategy for determining regional cerebral blood flow (rCBF) by positron emission tomography (PET). In that method, an inert diffusible indicator ([ I 50]water) is administered by i. v. infusion; mul tiple arterial blood samples are drawn to define the resulting arterial tracer activity curve; and a cere bral image is accumulated by PET over the time interval of TI to T 2 . rCBF is calculated from mea surements of the accumulated regional cerebral ac tivity and the arterial tracer concentration curve. Depending on the form of the arterial tracer input function, some values of TI and T 2 may result in multiple solutions for CBF (Ginsberg et aI. , 1982) .
following the bolus i. v. infusion of 20-30 fLCi of [ 1 50] water. Based on these arterial curves, it is confirmed that the C vs. frelationship resulting from scan parame ters TI = 0 and Tz = 1.5 min (i.e., a PET scan of 90 s commencing with tracer infusion) has an excellent sepa ration of flow values within the range of physiological interest, whereas a 90-s scan beginning at time TI = 1.7 min results in poorer separation of flow values and loss of the monotonic relationship between C and f at higher flows. The results of this study serve to clarify the in vivo auto radiographic method for measuring rCBF in humans and help to define favorable study parameters for assuring uniqueness and sensitivity of the flow measurement. Key Words: Autoradiography-Positron emission tomog raphy-Regional cerebral blood flow-Uniqueness the orems-[ 1 50]water.
To avoid this possibility in our experimental vali dation studies, we used a modified ramp i. v. infu sion that yielded an arterial activity curve which increased monotonically as a function of time and could be fit by a single polynomial.
When the in vivo autoradiographic method is used to measure rCBF in humans, it is desirable to shorten the interval required for i. v. tracer admin istration so as to maximize the cumulative cerebral activity and avoid loss of tracer activity by physical decay prior to its arrival in cerebral tissue. A second modification derives from the fact that many PET systems used for human studies do not readily permit the continuous measurement of cerebral ac tivity with moment-by-moment correction for phys ical decay of the tracer, such as was possible in our experimental validation studies (Ginsberg et aI. , 1982) . Thus, we have modified the operational equations of the method to allow a non-decay-cor rected mode of cumulative cerebral activity mea surement.
In considering the general form of the in vivo au toradiographic blood flow strategy as applied to human PET studies, it is crucial to determine if unique and sufficiently sensitive values of regional blood flow can, in principle, be computed, given the characteristics of the particular arterial tracer input function employed. In this report, we have derived a series of uniqueness theorems by which this goal may be accomplished, and we assess the suitability of an i. v. bolus tracer infusion paradigm for the computation of rCBF in humans.
THEORY
In this section, we summarize our theoretical fi ndings and emphasize their practical significance. The mathematical details have been placed in the Appendix.
Definition of symbols

A
Arterial concentration of tracer (fLCi/ml).
B
Cerebral tissue concentration of tracer (fLCi/g).
C
Cumulative cerebral tissue concentration of tracer (fLCi min/g). f CBF rate per weight of tissue (mllg/ minute). 
Theoretical background of the model
The in vivo autoradiographic strategy proposed by Ginsberg et al. (1982) is an outgrowth of the model of CBF formulated by Kety (1951) and based on the Fick principle. This asserts that the rate of change of cerebral tissue tracer concentration (B) is equal to its rate of increase minus its rate of de crease, or
where B' denotes dB/dt. With the initial condition B(O) = 0, the solution to this differential equation is
where the asterisk denotes the operation of con volution, namely,
[In the above expressions, semicolons separate classes of variables (variables, parameters, con stants), and commas separate entities in the same class. The constants IX and f... will be omitted from the arguments except where their presence needs to be emphasized. ]
The procedure to determine local blood flow con sists of several steps. Stated simply, these are: (1) intravenous injection of an appropriate radiolabeled tracer; (2) sequential sampling of the arterial tracer concentration A; (3) tomographic measurement of the cumulative local cerebral tracer concentration C; (4) evaluation of the function C(j) from the math ematical model (see Eqs. 2 and 4); (5) conversion of each value of C measured in step 3 to its corre sponding value of f by use of a table of conversion values, using the C vs. f relationship computed in step 4.
One problem which this article addresses is that of ensuring that the conversion of C to f is not am biguous. In other words, although C is a single valued function off, the inverse may not be single valued, so that more than one solution for fmay be possible. We seek to define the conditions that will ensure a unique blood flow determination.
New theory
Four uniqueness theorems have been developed, each establishing a different set of sufficient con ditions to ensure uniqueness of the blood flow de termination. The proofs, and derivation of the par tial derivative equations on which they rest, are pre sented in the Appendix. Here we state the theorems and their practical applications.
Uniqueness theorem I
Blood flow f is a unique function of C if TJ = 0. Application. This theorem states unequivocally that starting the PET scan at (or before) the onset of tracer arrival is sufficient to guarantee that the C vs. f curve is uniquely invertible; i. e. , that f is a unique function of the measured C, regardless of the nature of the arterial concentration curve, the radioactive decay rate, the brain-blood partition coefficient, or the values of C and f. (An example is shown in Fig. 3 . See Implementation of Theory, below. )
Uniqueness theorem II
A necessary and sufficient condition that f be a unique function of C is that a c/a f(f;0,T 2 ) > ac/af(f;O,T] ) (5) Note that this is the only one of the four theorems which is not only a sufficient but also a necessary condition for uniqueness. However, it depends on the shape of the arterial concentration curve, on the blood flow f, on the constants a and A, and on the times T] and T2• Application. In contrast to Theorem I, the utility of Theorem II lies in those situations in which one wishes to subdivide the total scan time into several intervals, so as to obtain a series of sequential PET scans. By so doing, one may compare blood flow data computed from summated scans having a va riety of start and stop times T] and T2, and in this manner analyze the stability and sensitivity char acteristics of the in vivo autoradiographic model of CBF. [We have recently completed an analysis of this type (Ginsberg et aI., 1983, in preparation) . ] This theorem is also useful in cases in which tech nical difficulties are encountered in the acquisition of early PET scan data, since it permits one to pre dict if a choice of later times T] and T2 will permit unique and sensitive values of flow to be computed. An example is shown in Fig. 5 (see Implementation of Theory, below).
Corollary 1. As long as A is a monotonically in creasing function of time, the sufficiency condition of Theorem II is satisfied. This was one motivation for the use of the i. v. ramp infusion in our earlier study (Ginsberg et aI., 1982) . The practical utility of this corollary is diminished when the maximum of the arterial tracer concentration curve A occurs at an early time, as in the case of the bolus-infusion method.
Corollary 2. As long as ac/af is an increasing function of time, the sufficiency condition of The orem II is satisfied.
Application. Curves of a c/a fvs. T for a sequence of values of f, computed from Eq. A6 (see Ap pendix) for a given arterial curve A(t), are helpful in delineating regions of uniqueness of blood flow determination. At lower values off (f < 1 mllg/min in a typical subject), we found that the ac/af curves tend to be strictly increasing, whereas for higher values off(f> 1. 25 mllg/min), the aClafcurves tend to have finite maxima and start to decrease with increasing values of T (T > 1 min in this subject). When this occurs, two different times (for example, T] and T 2 ) with the same value of aClafmay be read
from the curve. In this way, curves of (T2 -T]) vs. T] may be constructed for each tabulated f. These curves are contours of the surface (ac/a !) (f,'Tj,T2) = 0, which delineate the limits of regions of unique ness of blood flow determination.
Uniqueness theorem III
Blood flow f is a unique function of C if
This interesting result asserts that within the hy perbolafTz = A, one can be certain that the blood flow determination is unique, independent of the radioactive decay rate and the shape of the arterial concentration curve.
Application. This is a very powerful theorem. Unfortunately, it covers only a portion of the f, T2 region of interest.
Uniqueness theorem IV
There exists a particular value of e in the open interval ° < e < 1 such that blood flow fi s a unique function of C if (7) In contrast to Theorem III, the value of e depends on the radioactive decay rate and the shape of the arterial concentration curve.
Application. This theorem enlarges the region of Theorem III, but by an unknown amount. (The ex tent of the uniqueness range has to be known to compute the value of e.) Thus, its practical value is only qualitative. Since each theorem is a sufficient condition, one might assert that Theorem IV incor porates Theorem III. However, Theorem IV in volves an open interval, and e is dependent on the decay rate and arterial concentration curve, whereas Theorem III covers one endpoint of that region and is independent of decay rate and arterial concentration.
Comparing the four theorems, we see that they differ in the following respects: Theorem I applies to any arterial concentration curve, to any radio active decay rate, and to any value of blood flow, but restricts T] to zero. Theorem II applies to any set of T] and T2 values (T] < T2), but depends on the shape of the arterial concentration curve, and on a, A, andf. Theorem III is independent of A and a, whereas Theorem IV is not; they both relate A, f, and time. Theorem IV gives more generous bounds than does Theorem III, but Theorem III establishes one endpoint of the open interval of Theorem IV, and its proof is more direct. Thus, all four theorems are useful, but in different ways.
IMPLEMENTATION OF THEORY
To be useful, the theory must be applicable to empirical data in a practical way. This implies a computer program to interpolate the data (with or without smoothing), and to integrate the model nu merically. A computer program has been written in FORTRAN and implemented on a Perkin-Elmer 3220 computer. The program interpolates the raw data by linear spline and integrates the model by the trapezoidal rule. Ta bles of B, C, and aClaf for each (t,A) pair are computed recursively by the fol lowing equations for i = 1 to n -1 (see Appendix for derivations; this program is available from the authors on request):
Here, S is the convolution of B(t) and exp( -kt). These equations assume the following initial con ditions:
All programs were validated by applying them to an analytic function of the form (a)(t)exp( -bt) (which can be formally integrated to yield analytic expressions for B, C, and aClaf) as a standard of reference. The results were in agreement with the uniqueness theorems. In addition, it was felt necessary to consider ar terial tracer activity data derived from a small number of studies on human subjects to demon strate the utility of these principles in practice and to assure ourselves of their validity empirically. We used arterial data from three normal subjects aged 26-30 years, in whom rCBF studies were per formed by the in vivo autoradiographic strategy. Each subject was studied under resting conditions. The left radial artery was catheterized percuta neously with a short 20-gauge catheter for sequen tial measurement of arterial radiotracer concentra tion.
[,50]Water was used as the blood flow tracer. The positron-emitting radionuclide 1 50 (half-life, 123 s) was prepared with a CS-30 cyclotron (Cyclotron Corp.) by the 1 60(p,pn) 1 50 nuclear reaction, and [,50 ]water was synthesized as described previously (Rubio et al., 1981; Ginsberg et al., 1982) . The tracer, in a dose of 20-30 mCi, was mixed with isotonic saline and administered at time 0 as an i.v. bolus. Sequential arterial blood samples were col lected at 4-5-s intervals during the ensuing 3.2 min from the short, freely flowing radial artery catheter, the volume of which was cleared prior to each sample. The net weight of each arterial sample was determined, and its activity was measured in a well counter and corrected for physical decay to the time of sampling.
The B(f ;t) and C(f ;O,T) surfaces for each subject were determined from the measured arterial con centration curve A by the numerical procedure de scribed above. (To satisfy the initial conditions of Eqs. 8-13, the time to was computed by linear ex trapolation backward from the first two significant A values to A = 0.) The arterial tracer activity data were sufficiently smooth that linear spline interpo lation yielded satisfactory results without additional smoothing.
A value of 0.95 was used for the brain-blood par tition coefficient >-, consistent with the value di rectly measured in our previous study (Ginsberg et al., 1982) . This value of>-has been used widely in previous studies employing [ 1 50]water (Eichling et al., 1974; Raichle et al., 1976) , and is also consistent with the value computed on the basis of the frac tional water contents of brain (Widdowson and Dickerson, 1960; Katzman and Pappius, 1973) and blood (Dittmer, 1961) .
Arterial activity input function
After a variable delay (averaging 0.44 ± 0.15 min), arterial tracer activity rose rapidly in all sub jects, peaked sharply, and fell steeply, followed by a gradually declining tail. Peak arterial activity was 5.23 ± 1.9 ,... . Ci/ml (mean ± SD) for the three sub jects. Curve shapes were similar in all subjects. A representative arterial tracer activity curve is shown in Fig. 1 . Because of the early steep rise in arterial tracer activity following bolus i. v. tracer ad ministration, it was essential to perform frequent arterial sampling during the early portion of the study, so as to define the arterial tracer curve as accurately as possible.
Instantaneous cranial activity
Curves of instantaneous cranial activity B(f;t) were generated for each subject from the arterial input function A(t), for flow values extending from zero to the moderately supraphysiological range (2 mllg/min). A representative series of B curves is shown in Fig. 2 . Inspection of these curves reveals that cranial activity peaked during the first 1.5 min of the study. An implication of this finding is that a measurement of cumulative cranial activity C car- ried out during the first 1. 5 min would be expected to yield counting statistics superior to those re sulting from a comparable measurement made during the second 1. 5 -min interval.
Cumulative cranial activity
Cumulative cranial activity C(f;t) was generated from the arterial input curve ACt) by applying Eq. 4 as described above. subject, based on a scan start time (T1) of 0 min and variable scan stop times (T2) ranging up to 1.5 min. Longer cumulative scans, as expected, are associ ated with higher levels of cranial activity for a given value of flow. Within the physiological flow range of 0 to 1 mllg/min, the f vs. C relationship departs only modestly from linearity. Importantly, a mono tonic relationship between f and C is preserved throughout the flow range shown, consistent with the prediction of Theorem I for the condition Tl = o (see Theory).
To provide necessary experimental confirmation of theoretical predictions, a scan start time (T1) of 1. 7 min was also considered. Figure 4 shows a series of C vs. f curves for a series of scan stop times T2 ranging up to 3.2 min. As anticipated, in contradistinction to the curves of Fig. 3 , the rela tionship between f and C becomes markedly cur vilinear at flow values of 0. 5 mllg/min and above, and monotonicity is lost in the higher portion of the flow range shown. These empirical results are con sistent with the prediction of Theorem II as illus trated in Fig. 5 . In this example, curves of (aCI af)(f;o,T) vs. f are shown for two values of T in a normal subject. It is seen that these curves inter sect. This intersection identifies an f, Tj, T2 where aC/af = 0; that is, where C(f) has a finite max imum, and the inverse is not unique. The indepen dently calculated CCf) curve confirms this finding.
Comparison of the ordinates of Figs. 3 and 4 re veals that the absolute magnitude of cumulative cra- Tl of 1.7 min and variable stop times T2 extending to 3. 2 min. The C vs. flow relationship is much more curvilinear than in Fig. 3 , and the monotonic relationship between C and flow is lost at higher flow values.
., q .,
cl f ..: nial activity would be considerably less for a PET scan performed between 1.7 and 3.2 min than for one performed between 0 and 1.5 min following bolus tracer administration, as had been predicted from Fig. 2 . In Fig. 6 the individual curves of flow vs. cu mulative cranial activity C for the three subjects are shown. In the top row, T] = 0 min and T2 = 1.5 min; in the bottom row, T] = 1. 7 min and Tz = 3.2 min. In all subjects, the earlier parameters guar antee uniqueness and satisfactory separation of blood flow values throughout the physiological range. In contrast, the latter values are associated with a highly nonlinear relationship between f and C, even at lower values of flow, as well as lack of monotonicity at higher f values, resulting in non unique flow solutions for certain values of C. The maximum in these curves occurs at flow values of 1.19 ± O. lO ml/g/min (mean ± SD).
DISCUSSION
The in vivo autoradiographic strategy appears to be well suited to the determination of rCBF in hu mans by emission tomography: The method re quires only a brief scanning period (2 min or less), thus rendering compliance with the steady-state as sumption of the model more likely. The model equa tions permit CBF to be computed from a knowledge of cumulative cranial tracer activity, to which PET is well-suited, rather than requiring sequential mea surements of cranial clearance, for which emission tomography in its present form is ill-equipped. A further advantage is that the mathematical model underlying the method places no constraints on the precise form of the arterial tracer activity function, thus obviating the need for a precisely prepro grammed arterial input function. In our earlier val idation studies of this model in the rat, a modified ramp i. v. infusion was used so as to yield an arterial tracer function which could be readily fit by a single polynomial, thus simplifying the calculation of CBF. In preliminary human studies (Ginsberg et aI. , un published observations), however, the use of an i. v. ramp infusion of tracer was associated with an un acceptably low level of cranial activity owing to physical decay of the 1 50 nuclide prior to its arrival in the cranium, thus rendering precise computation of CBF impossible. In contrast, the i.v. bolus in fusion method maximizes the early delivery of tracer to the brain.
A major goal of the present study was to inves tigate the conditions under which one could be as sured that unique (i. e. , nonmultiple) values of rCBF
C')
., C') ... would be obtained. That uniqueness of blood flow determination may not be trivially assured is sug gested by the previous results of Ginsberg et al. (1982) . This was borne out in the examples pre sented above by the finding that multiple solutions for rCBF (f ) were possible when a scanning interval of 1. 7 -3.2 min following tracer administration was selected (Fig. 4 and Fig. 6 , bottom row). The uniqueness theorems were derived in an effort to specify a set of study conditions sufficient to guar antee a unique solution for rCBF. Importantly, The orem I states that a unique solution for flow is as sured whenever the start time TI of the PET scan is zero. The results of this study for the case Tl two requirements are mutually opposing: the tomo graphic image benefits from a large number of reg istered events in order to reduce the effect of sta tistical noise, whereas the uniqueness theorems in dicate the desirability of measurements as early as possible to guarantee uniqueness and maximal ac curacy of blood flow determination (a e/a ! as large as possible). The bolus i.v. tracer infusion paradigm appears to meet each of these needs in that it results in the rapid delivery of large amounts of tracer to the brain, enabling the tomograph to record images that are short in duration and have satisfactory signal-to-noise characteristics. [The latter point has been substantiated in detail in a subsequent series of human subjects (Ginsberg et aI., 1983, in prepa ration) .] Huang et al. (1982) recently proposed a "general input technique" for estimating local CBF, based on the same single-compartment flow model as that of the present study (see Eq. 1), but requiring that cumulative cranial activity be acquired by the to mograph in both the decay-corrected and non-decay-corrected mode. Both that method and ours, however, allow flexibility in respect to the shape of the arterial input function. Raichle et al. (198l) have also evaluated the suitability for human PET studies of an integrated single-compartment approach based on the Kety model.
In summary, the in vivo aut 0 radiographic method employing a short scanning period yields a relation ship between cumulative cranial activity C and flow which is only mildly curvilinear and in which there is excellent sensitivity to flow changes within the physiological range (Fig. 6, upper panels) . In con trast, the widely used rCBF method employing the continuous inhalation of [ 1 50]carbon dioxide re quires that the tracer be administered at a constant rate over a much longer period (6-8 min) to achieve equilibrium in the brain, and is characterized by relatively poor sensitivity of C to changes of flow within and above the normal gray-matter flow range (Subramanyam et aI., 1978; Frackowiak et aI., 1980) . A comprehensive treatment of factors af fecting the computational stability of the in vivo au toradiographic method is currently being prepared for publication (Ginsberg et aI., 1983, in prepara tion) . 
Equations A7-A13 are obtained by standard par tial differentiation and limits, and are seen to be internally consistent. The result is the following qualitative description of the c(f;O,n surface (Fig.   3 is an example of such a surface): The surface is zero along both axes. In the T direction, a cross section perpendicular to the f-axis is a sigmoid curve, starting with zero slope for all f, climbing to the maximum slope, then continuing strictly to in crease, with its slope decreasing to zero (Eq. AI2) as C approaches a horizontal asymptote (Eq. AlO).
In the f direction, a cross section perpendicular to the T-axis is a curve of a shape similar to that of a curve describing charge as a function of time in a charging electrical condenser; vi z., the C vs,f cross section starts with a finite positive slope (for T > 0, Eq. A9), then strictly increases with slope de creasing to zero (Eq. AI2), as C approaches a hor izontal asymptote (Eq. All).
We are now in a position to prove the uniqueness theorems.
Uni queness theorem I
Blood flow f is a unique function of C if TI = 0. Proof. The Inverse Function Theorem (Olm stead, 1961, pp. 50, 80) states that C is a uniquely invertible function of f in any region where C is strictly increasing, and this will be true if aCiaf > 0. Equation A4 is an expression for aCiaf when TI = 0. Since, for T> 0, the two terms with which A is convolved are both positive, thus for any positive A, ac/af> ° for T> 0. The same conclusion results from Eq. A6, Q.E.D. Uni queness theorem II A necessary and sufficient condition that blood flow f be a unique function of C is that Proof. All factors in Eq. A5 are positive except the first; the stated condition is sufficient to make it so, Q.E.D. Uni queness theorem IV There exists a particular value of e in the interval 0< e < I such that blood flow fis a unique function of C if fTz < A/e.
Proof. The Mean Value Theorem I is applied twice to a slightly changed Eq. A5 (with the limits of integration from TI to T2 instead of ° to T), yielding ac = (.1 _ e � ) c , (0 < e < 1), (TI < � < T2) af f A
The result follows by taking the worst value for �, Q.E.D.
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